Haploidentical and unrelated donor transplantation have similar risks of acute and chronic graft-versus-host disease
Haploidentical and unrelated donor recipients have similar probabilities of survival
Human Herpesvirus-6 reactivation is higher for haploidentical transplant recipients
Platelet recovery, but not neutrophil recovery, is faster using peripheral blood stem cells for haploidentical transplants
Haploidentical transplantation may achieve more robust early lymphoid engraftment